Detalhe da pesquisa
1.
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes.
Am J Respir Crit Care Med
; 206(5): 545-553, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35549845
2.
Corticosteroid Responsiveness Following Mepolizumab in Severe Eosinophilic Asthma-A Randomized, Placebo-Controlled Crossover Trial (MAPLE).
J Allergy Clin Immunol Pract
; 10(11): 2925-2934.e12, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35863669